NCT00150332 - Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

January 31, 2006

Conditions

Infections, Nosocomial

Interventions

DRUG

linezolid

Trial Locations (20)

296-0041

Pfizer Investigational Site, Kamogawa

811-0213

Pfizer Investigational Site, Fukuoka

813-0025

Pfizer Investigational Site, Fukuoka

807-0051

Pfizer Investigational Site, Onga-gun

730-8619

Pfizer Investigational Site, Hiroshima

734-8530

Pfizer Investigational Site, Hiroshima

060-8648

Pfizer Investigational Site, Sappopro

006-8555

Pfizer Investigational Site, Sapporo

302-0118

Pfizer Investigational Site, Moriya

236-0051

Pfizer Investigational Site, Yokohama

615-8256

Pfizer Investigational Site, Kyoto

854-8501

Pfizer Investigational Site, Isahaya

852-8501

Pfizer Investigational Site, Nagasaki

701-0912

Pfizer Investigational Site, Kurashiki

Unknown

Pfizer Investigational Site, Kurashiki

700-8505

Pfizer Investigational Site, Okayama

703-8275

Pfizer Investigational Site, Okayama

565-8565

Pfizer Investigational Site, Suita

350-0495

Pfizer Investigational Site, Iruma-gun

187-0004

Pfizer Investigational Site, Kodaira